Rise Advisors, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Rise Advisors, LLC
- $207 Million
- Q3 2024
A detailed history of Rise Advisors, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 70 shares of AMPH stock, worth $3,091. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70
Previous 50
40.0%
Holding current value
$3,091
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AMPH
# of Institutions
286Shares Held
35.1MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$262 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$120 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$94.3 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$86 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$71.3 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.16B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...